Your browser doesn't support javascript.
loading
Avelumab plus Axitinib for the Treatment of Patients with End-Stage Renal Disease Undergoing Dialysis: A Retrospective Case Series and Literature Review.
Bando, Yukari; Furukawa, Junya; Hara, Takuto; Okamura, Yasuyoshi; Terakawa, Tomoaki; Nakano, Yuzo; Fujisawa, Masato.
Afiliação
  • Bando Y; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Furukawa J; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Hara T; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Okamura Y; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Terakawa T; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Nakano Y; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Fujisawa M; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
Urol Int ; 107(3): 321-326, 2023.
Article em En | MEDLINE | ID: mdl-36731453
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Falência Renal Crônica / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Urol Int Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Falência Renal Crônica / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: Urol Int Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão